Literature DB >> 23707940

miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4.

Liang Chen1, Yanping Tang, Jian Wang, Zhongjie Yan, Ruxiang Xu.   

Abstract

microRNAs have been demonstrated to play important roles in cancer development and progression. Hence, identifying functional microRNAs and better understanding of the underlying molecular mechanisms would provide new clues for the development of targeted cancer therapies. Herein, we reported that a microRNA, miR-421 played an oncogenic role in nasopharyngeal carcinoma. Upregulation of miR-421 induced, whereas inhibition of miR-421 repressed cell proliferation and apoptosis resistance. Furthermore, we found that upregulation of miR-421 inhibited forkhead box protein O4 (FOXO4) signaling pathway following downregulation of p21, p27, Bim and FASL expression by directly targeting FOXO4 3'UTR. Additionally, we demonstrated that FOXO4 expression is critical for miR-421-induced cell growth and apoptosis resistance. Taken together, our findings not only suggest that miR-421 promotes nasopharyngeal carcinoma cell proliferation and anti-apoptosis, but also uncover a novel regulatory mechanism for inactivation of FOXO4 in nasopharyngeal carcinoma.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707940     DOI: 10.1016/j.bbrc.2013.05.056

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.

Authors:  Shuguang Zhou; Bing Wang; Jun Hu; Yucheng Zhou; Mengzhen Jiang; Mingyu Wu; Liming Qin; Xuming Yang
Journal:  Tumour Biol       Date:  2016-01-13

Review 2.  Posttranscriptional regulation of FOXO expression: microRNAs and beyond.

Authors:  P Urbánek; L-O Klotz
Journal:  Br J Pharmacol       Date:  2016-05-02       Impact factor: 8.739

3.  MiR-421 Is Overexpressed and Promotes Cell Proliferation in Non-Small Cell Lung Cancer.

Authors:  Xing Li; Shao-Hua Chen; Jin-Wu Zeng
Journal:  Med Princ Pract       Date:  2019-09-02       Impact factor: 1.927

Review 4.  Cellular microRNAs and picornaviral infections.

Authors:  Miao Wang; Zeqian Gao; Li Pan; Yongguang Zhang
Journal:  RNA Biol       Date:  2014-06-12       Impact factor: 4.652

Review 5.  Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.

Authors:  Ya-Kai Huang; Jian-Chun Yu
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

6.  miR-617 Promotes the Growth of IL-22-Stimulated Keratinocytes Through Regulating FOXO4 Expression.

Authors:  Tao Liu; Xiaomei Feng; Yongmei Liao
Journal:  Biochem Genet       Date:  2020-11-19       Impact factor: 1.890

7.  Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma.

Authors:  Yu Li; Wei Li; Jian-Guo Zhang; Hai-Yang Li; Yong-Ming Li
Journal:  Tumour Biol       Date:  2014-07-11

8.  RNA-seq Analysis of δ9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation.

Authors:  Xiaoming Yang; Marpe Bam; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Biol Chem       Date:  2016-06-06       Impact factor: 5.157

9.  miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase.

Authors:  Yunfei Zhou; Guohui Wan; Riccardo Spizzo; Cristina Ivan; Rohit Mathur; Xiaoxiao Hu; Xiangcang Ye; Jia Lu; Fan Fan; Ling Xia; George A Calin; Lee M Ellis; Xiongbin Lu
Journal:  Mol Oncol       Date:  2013-10-08       Impact factor: 6.603

10.  MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.

Authors:  Jennifer Drahos; Katrin Schwameis; Linda D Orzolek; Haiping Hao; Peter Birner; Phillip R Taylor; Ruth M Pfeiffer; Sebastian F Schoppmann; Michael B Cook
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-24       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.